©2011-2018 Open Source Electronic Health Record Alliance
This work is licensed under a Creative Commons Attribution 3.0 Unported License
This work is licensed under a Creative Commons Attribution 3.0 Unported License
| Package | Total | Routines |
|---|---|---|
| Lab Service | 15 | LRCONJAM ^LR ACCESSION NUMBER LR7OSAP2 LRAPAUSR LRAPS2 LRAUL LRAURPT LRBLP LRPARAM LRUTL LRVER2 LRVR2 RELATED NAME SPECIMEN # |
| ICR LINK | Subscribing Package(s) | Fields Referenced | Description |
|---|---|---|---|
| ICR #4469 | DATE/TIME SPECIMEN TAKEN (.01). Access: Direct Global Write & w/Fileman DATE REPORT COMPLETED (.03). Access: Direct Global Write & w/Fileman ENTERING PERSON (.04). Access: Direct Global Write & w/Fileman SPECIMEN (.05). Access: Direct Global Write & w/Fileman COLLECTION SAMPLE (.055). Access: Direct Global Write & w/Fileman ACCESSION NUMBER (.06). Access: Direct Global Write & w/Fileman PHYSICIAN (.07). Access: Direct Global Write & w/Fileman WARD (.08). Access: Direct Global Write & w/Fileman PHLEBOTOMIST (.09). Access: Direct Global Write & w/Fileman DATE/TIME RECEIVED (.1). Access: Direct Global Write & w/Fileman ACCESSION LINK (.12). Access: Direct Global Write & w/Fileman SPECIMEN COMMENT (.99). Access: Direct Global Write & w/Fileman DIRECT AHG(POLYSPECIFIC) (2.1). Access: Direct Global Write & w/Fileman DIRECT AHG(5 min incub) (2.2). Access: Direct Global Write & w/Fileman DIRECT AHG CC (2.3). Access: Direct Global Write & w/Fileman ANTI-IgG (2.4). Access: Direct Global Write & w/Fileman ANTI-IgG CC (2.5). Access: Direct Global Write & w/Fileman ANTI-COMPLEMENT (2.6). Access: Direct Global Write & w/Fileman ANTI-COMPLEMENT (5 min incub) (2.7). Access: Direct Global Write & w/Fileman ANTI-COMPLEMENT CC (2.8). Access: Direct Global Write & w/Fileman DIRECT AHG INTERPRETATION (2.9). Access: Direct Global Write & w/Fileman DIRECT AHG TEST COMMENT (2.91). Access: Direct Global Write & w/Fileman ELUATE ANTIBODY (3). Access: Direct Global Write & w/Fileman SCREEN CELL METHOD (4). Access: Direct Global Write & w/Fileman ANTIBODY SCREEN INTERPRETATION (6). Access: Direct Global Write & w/Fileman RBC ANTIGEN PRESENT (6.1). Access: Direct Global Write & w/Fileman RBC ANTIGEN ABSENT (6.2). Access: Direct Global Write & w/Fileman HLA ANTIGEN PRESENT (6.3). Access: Direct Global Write & w/Fileman HLA ANTIGEN ABSENT (6.4). Access: Direct Global Write & w/Fileman SERUM ANTIBODY (7). Access: Direct Global Write & w/Fileman ANTIBODY SCREEN COMMENT (8). Access: Direct Global Write & w/Fileman RBC TYPING METHOD (9). Access: Direct Global Write & w/Fileman PT CELLS+ANTI D (121). Access: Direct Global Write & w/Fileman PT CELLS+RH CTRL (122). Access: Direct Global Write & w/Fileman PT CELLS(sal)+ANTI D(hp IS) (123). Access: Direct Global Write & w/Fileman PT CELLS(ser)+ANTI D(hp IS) (124). Access: Direct Global Write & w/Fileman PT CELLS+ANTI D (hp 37) (125). Access: Direct Global Write & w/Fileman PT CELLS+ANTI D (hp AHG) (126). Access: Direct Global Write & w/Fileman PT CELLS+ANTI D SLIDE (hp) (127). Access: Direct Global Write & w/Fileman PT CELLS(sal)+RH CTRL (hp IS) (128). Access: Direct Global Write & w/Fileman PT CELLS(ser)+RH CTRL(hp IS) (129). Access: Direct Global Write & w/Fileman PT CELLS+RH CTRL (hp 37) (129.1). Access: Direct Global Write & w/Fileman PT CELLS+RH CTRL (hp AHG) (129.11). Access: Direct Global Write & w/Fileman PT CELLS+RH CTRL SLIDE (hp) (129.12). Access: Direct Global Write & w/Fileman INTERPRETATION OF RH TESTING (131). Access: Direct Global Write & w/Fileman RH TEST COMMENT (132). Access: Direct Global Write & w/Fileman PT Cells(sal)+Anti D(mod) IS (133). Access: Direct Global Write & w/Fileman PT Cells(ser)+Anti D(mod) IS (134). Access: Direct Global Write & w/Fileman PT Cells+Anti D(mod) 37 (135). Access: Direct Global Write & w/Fileman PT Cells+Anti D(mod) AHG (136). Access: Direct Global Write & w/Fileman PT Cells(sal)+RH Ctrl(sal) IS (138). Access: Direct Global Write & w/Fileman PT Cells(ser)+RH Ctrl(sal) IS (139). Access: Direct Global Write & w/Fileman PT Cells+RH Ctrl(sal) 37 (139.1). Access: Direct Global Write & w/Fileman PT Cells+RH Ctrl(sal) AHG (139.11). Access: Direct Global Write & w/Fileman PT CELLS(ser)+ANTI A IS (141). Access: Direct Global Write & w/Fileman PT CELLS(sal)+ANTI A IS (142). Access: Direct Global Write & w/Fileman PT CELLS+ANTI A SLIDE (143). Access: Direct Global Write & w/Fileman PT CELLS(ser)+ANTI B IS (144). Access: Direct Global Write & w/Fileman PT CELLS(sal)+ANTI B IS (145). Access: Direct Global Write & w/Fileman PT CELLS+ANTI B SLIDE (146). Access: Direct Global Write & w/Fileman PT CELLS(ser)+ANTI A,B IS (147). Access: Direct Global Write & w/Fileman PT CELLS(ser)+ANTI A,B (RT) (148). Access: Direct Global Write & w/Fileman PT CELLS(sal)+ANTI A,B (IS) (149). Access: Direct Global Write & w/Fileman PT CELLS(sal)+ANTI A,B (RT) (149.1). Access: Direct Global Write & w/Fileman PT CELLS+ANTI A,B SLIDE (149.11). Access: Direct Global Write & w/Fileman PT SERUM+A1 CELLS (149.12). Access: Direct Global Write & w/Fileman PT SERUM+B CELLS (149.13). Access: Direct Global Write & w/Fileman INTERPRETATION OF ABO TESTING (151). Access: Direct Global Write & w/Fileman ABO TESTING COMMENT (152). Access: Direct Global Write & w/Fileman INTERPRETATION ABO GROUP(cell) (153). Access: Direct Global Write & w/Fileman INTERPRETATION ABO GROUP(ser) (154). Access: Direct Global Write & w/Fileman SPECIMEN COMMENT (.01). Access: Direct Global Write & w/Fileman ELUATE ANTIBODY (.01). Access: Direct Global Write & w/Fileman SCREEN CELL METHOD (.01). Access: Direct Global Write & w/Fileman TECHNIQUE (.02). Access: Direct Global Write & w/Fileman SCREEN CELL (1). Access: Direct Global Write & w/Fileman SCREEN CELL (.01). Access: Direct Global Write & w/Fileman SOURCE (.02). Access: Direct Global Write & w/Fileman INTERPRETATION (.03). Access: Direct Global Write & w/Fileman IS (.04). Access: Direct Global Write & w/Fileman 37 C (.05). Access: Direct Global Write & w/Fileman AHG (.06). Access: Direct Global Write & w/Fileman CONTROL CELL (.07). Access: Direct Global Write & w/Fileman ROOM TEMP (.08). Access: Direct Global Write & w/Fileman 12-18 C (.09). Access: Direct Global Write & w/Fileman 4 C (.1). Access: Direct Global Write & w/Fileman RBC ANTIGEN PRESENT (.01). Access: Direct Global Write & w/Fileman COMMENT (.02). Access: Direct Global Write & w/Fileman RBC ANTIGEN ABSENT (.01). Access: Direct Global Write & w/Fileman COMMENT (.02). Access: Direct Global Write & w/Fileman HLA ANTIGEN PRESENT (.01). Access: Direct Global Write & w/Fileman COMMENT (2). Access: Direct Global Write & w/Fileman HLA ANTIGEN ABSENT (.01). Access: Direct Global Write & w/Fileman COMMENT (2). Access: Direct Global Write & w/Fileman SERUM ANTIBODY (.01). Access: Direct Global Write & w/Fileman ANTIBODY COMMENT (.02). Access: Direct Global Write & w/Fileman ANTIBODY SCREEN COMMENT (.01). Access: Direct Global Write & w/Fileman RBC TYPING METHOD (.01). Access: Direct Global Write & w/Fileman TECHNIQUE (.02). Access: Direct Global Write & w/Fileman ANTISERUM (1). Access: Direct Global Write & w/Fileman ANTISERUM (.01). Access: Direct Global Write & w/Fileman LOT # (.02). Access: Direct Global Write & w/Fileman INTERPRETATION (.03). Access: Direct Global Write & w/Fileman IS (.04). Access: Direct Global Write & w/Fileman 37 C (.05). Access: Direct Global Write & w/Fileman AHG (.06). Access: Direct Global Write & w/Fileman CONTROL CELL (.07). Access: Direct Global Write & w/Fileman ROOM TEMP (.08). Access: Direct Global Write & w/Fileman 12-18 C (.09). Access: Direct Global Write & w/Fileman 4 C (.1). Access: Direct Global Write & w/Fileman |